iOMEDICO conducts Phase I-IV clinical trials and prospective tumour registries. Further, as an academically oriented research institute, we focus on Investigator-initiated trials (IIT). With oncological expertise from practice and clinic, as well as long-standing experience, we design high-quality research projects, precisely fitting the latest oncological challenges. Our aim is to pave the way to new treatment strategies for patients and to enhance the quality of therapy.
As a Clinical Research Organisation (CRO), we offer you all services of clinical research from a single source: From design to publication.
Joint research for all concerned
Medical research is a team effort. Close cooperation with national and international study groups and expert associations, the research-based pharmaceutical industry, as well as a high-performance investigator network contribute to the success of our projects. We support your research project likewise with our professional structures and partners – fast, competent and confidential. Feel free to contact us with your request.
Translational research and precision oncology
Molecular diagnostic progress allows us to understand the processes inside the tumour cell much better. Tumour profiles decide about the treatment plan and possible study participation. Biobanking and cross-over analysis between clinical trial and Real World data, helps to identify new treatment options that can be applied targeted and evidence-based.
Awards, distinctions and publications
iOMEDICO’s research results are presented and published nationally and internationally. They have won several awards, were internationally distinguished as clinically relevant and were selected for the Best Abstract- or Best of Congress-sessions. We feel obliged to this high level of our research work.